The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Solid Tumor Cancer Treatment Market At The End Of The 2026–2030 Forecast Period?
The market for solid tumor cancer treatments has seen rapid expansion in recent years. It is anticipated to increase from $265.41 billion in 2025 to $301.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.4%. This historical growth can be attributed to several factors including a rise in cancer incidence, the adoption of chemotherapy, advancements in radiation therapy, increased oncology funding, and improvements in early diagnosis techniques.
The solid tumor cancer treatment market is anticipated to experience significant expansion in the upcoming years. It is projected to achieve a size of $501.28 billion by 2030, progressing at a compound annual growth rate (CAGR) of 13.6%. The expansion observed during the forecast period is propelled by factors such as immunotherapy approvals, advancements in targeted drug pipelines, increased adoption of personalized medicine, expansion of oncology infrastructure, and enhancements in survival rates. Notable developments during this period encompass the rise of checkpoint inhibitors, the broadening of tumor-agnostic therapies, a greater utilization of combination regimens, the increasing prevalence of biomarker-driven treatments, and the growth in outpatient oncology services.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9909&type=smp
What Drivers Are Shaping The Future Growth Of The Solid Tumor Cancer Treatment Market?
The rising occurrence of cancer substantially fuels the expansion of the solid tumor cancer treatment market in the future. This grave condition involves the rapid and uncontrolled proliferation of body cells, leading to abnormal growths. Solid tumor cancer treatment involves therapeutic approaches designed to extract solid tumors from cancer patients’ bodies. For example, data from April 2024 by the World Health Organization, an international public health body based in Switzerland, indicated that almost 20 million new cancer cases were recorded in 2022, causing about 10 million fatalities from the illness. Projections based on demographics forecast that the yearly incidence of cancer could climb to 35 million by 2050, signifying a 77% surge compared to 2022 data. Lung cancer emerged as the most frequently identified type, contributing around 2.5 million new cases, which is equivalent to one in every eight cancers globally and accounts for 12.4% of all global cancer diagnoses. Consequently, the growing prevalence of cancer is propelling the development of the solid tumor cancer treatment market.
What Segment Types Make Up The Solid Tumor Cancer Treatment Market?
The solid tumor cancer treatment market covered in this report is segmented –
1) By Type: Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures
2) By Application: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications
3) By End-Users: Hospitals, Research Institutes, Homecare
Subsegments:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Mitotic Inhibitors
2) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Signal Transduction Inhibitors
3) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines
4) By Hormone Therapy: Aromatase Inhibitors, Anti-Androgens, Selective Estrogen Receptor Modulators (SERMs)
5) By Surgical Procedures: Tumor Resection, Laparoscopic Surgery, Robotic-Assisted Surgery
Which Trends Are Influencing The Solid Tumor Cancer Treatment Market?
Key companies operating within the solid tumor cancer treatment market are concentrating on developing advanced immunotherapies, targeted therapies, and cell-based treatments to improve patient outcomes and broaden therapeutic options. For instance, in July 2025, Dispatch Bio, a US-based biotechnology company, began operations with the goal of creating universal treatments for solid tumors. The company intends to advance novel therapeutic approaches that aim to target a wide array of solid tumor types, enhance efficacy among patient populations, and accelerate the development of scalable cancer immunotherapies, potentially transforming standard-of-care treatment and elevating long-term survival rates.
Who Are The Key Players Driving Competition In The Solid Tumor Cancer Treatment Market?
Major companies operating in the solid tumor cancer treatment market are AstraZeneca plc, Amgen Inc., Bristol Myers Squibb & Company, Eli Lilly & Company, F Hoffmann La Roche Ltd, Merck & Co Inc, Novartis AG, Pfizer Inc, Olympus Medical Systems, Astellas Pharma Inc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd, Celldex Therapeutics Inc, AbbVie Inc, Bayer AG, Eisai Co Ltd, Exelixis Inc, Genentech Inc, Gilead Sciences Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Karyopharm Therapeutics Inc, Kyowa Kirin Co Ltd, MorphoSys AG, Regeneron Pharmaceuticals Inc, Sanofi SA, Seattle Genetics Inc, Spectrum Pharmaceuticals Inc, Taiho Pharmaceutical Co Ltd, Verastem Inc, Zymeworks Inc
Read the full solid tumor cancer treatment market report here:
https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report
Which Geographic Regions Are Influencing Demand In The Solid Tumor Cancer Treatment Market?
North America was the largest region in the solid tumor cancer treatment market in 2025. The regions covered in the solid tumor cancer treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Solid Tumor Cancer Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=9909&type=smp
Browse Through More Reports Similar to the Global Solid Tumor Cancer Treatment Market 2026, By The Business Research Company
Solid Tumor Testing Global Market Report
https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report
Bone Cancer Treatment Global Market Report
https://www.thebusinessresearchcompany.com/report/bone-cancer-treatment-global-market-report
Intratumoral Cancer Therapies Global Market Report
https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model